Critical Need for Clarity in Polymyxin B Dosing

about

Population pharmacokinetics of polymyxin B in acutely ill adult patients.Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

P2860

Q47195590-CC07C0CD-16A0-44EB-A953-78C996B2968A Q49171317-C66E0434-BAF2-48BA-8077-A38BF8004571

P2860

Critical Need for Clarity in Polymyxin B Dosing

Item

http://www.wikidata.org/entity/Q42358815

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Critical Need for Clarity in Polymyxin B Dosing

@en

Critical Need for Clarity in Polymyxin B Dosing

@nl

type

Item

label

Critical Need for Clarity in Polymyxin B Dosing

@en

Critical Need for Clarity in Polymyxin B Dosing

@nl

prefLabel

Critical Need for Clarity in Polymyxin B Dosing

@en

Critical Need for Clarity in Polymyxin B Dosing

@nl

P1476

Critical Need for Clarity in Polymyxin B Dosing

@en

P2093

Alan Forrest

http://www.w3.org/2001/XMLSchema#string

Gauri G Rao

http://www.w3.org/2001/XMLSchema#string

Jason M Pogue

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Keith S Kaye

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods

Comparative Pharmacokinetic Profiling of Different Polymyxin B Components.

Feedback control methods for drug dosage optimisation. Concepts, classification and clinical application.

Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.

Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study.

Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.

Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis.

Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report

Pharmacokinetics of intravenous polymyxin B in critically ill patients.

Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections.

P31

scholarly article

P356

10.1128/AAC.00208-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc H. Scheetz

Roger L Nation

Nikolas J Onufrak

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28438796

http://www.w3.org/2001/XMLSchema#string

P932

5404569

http://www.w3.org/2001/XMLSchema#string

Critical Need for Clarity in Polymyxin B Dosing

about

P2860

P2860

Critical Need for Clarity in Polymyxin B Dosing

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932